Show simple item record

Authordc.contributor.authorVidela Cabrera, Luis 
Authordc.contributor.authorFernández Arancibia, Virginia 
Authordc.contributor.authorCornejo, Pamela 
Authordc.contributor.authorVargas, Romina 
Authordc.contributor.authorCastillo Montecinos, Iván 
Admission datedc.date.accessioned2016-01-14T13:40:11Z
Available datedc.date.available2016-01-14T13:40:11Z
Publication datedc.date.issued2015
Cita de ítemdc.identifier.citationExpert Reviews in Molecular Medicine Volumen: 17 Número de artículo: e10 May 2015en_US
Identifierdc.identifier.issn1462-3994
Identifierdc.identifier.otherDOI: 10.1017/erm.2015.8
Identifierdc.identifier.urihttps://repositorio.uchile.cl/handle/2250/136505
General notedc.descriptionArtículo de publicación ISIen_US
General notedc.descriptionSin acceso a texto completo
Abstractdc.description.abstractThyroid hormone (TH) exerts important actions on cellular energy metabolism, accelerating O-2 consumption with consequent reactive oxygen species (ROS) generation and redox signalling affording cell protection, a response that is contributed by redox-independent mechanisms. These processes underlie genomic and non-genomic pathways, which are integrated and exhibit hierarchical organisation. ROS production led to the activation of the redox-sensitive transcription factors nuclear factor-kappa B, signal transducer and activator of transcription 3, activating protein 1 and nuclear factor erythroid 2-related factor 2, promoting cell protection and survival by TH. These features involve enhancement in the homeostatic potential including antioxidant, antiapoptotic, antiinflammatory and cell proliferation responses, besides higher detoxification capabilities and energy supply through AMP-activated protein kinase upregulation. The above aspects constitute the molecular basis for TH-induced preconditioning of the liver that exerts protection against ischemia-reperfusion injury, a strategy also observed in extrahepatic organs of experimental animals and with other types of injury, which awaits application in the clinical setting. Noteworthy, re-adjusting TH to normal levels results in several beneficial effects; for example, it lengthens the cold storage time of organs for transplantation from brain-dead donors; allows a superior neurological outcome in infants of <28 weeks of gestation; reduces the cognitive side-effects of lithium and improves electroconvulsive therapy in patients with bipolar disordersen_US
Patrocinadordc.description.sponsorshipFONDECYT (Chile) 1120034en_US
Lenguagedc.language.isoenen_US
Publisherdc.publisherCambridge University Pressen_US
Type of licensedc.rightsAtribución-NoComercial-SinDerivadas 3.0 Chile*
Link to Licensedc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/*
Keywordsdc.subjectActivated protein-kinase
Keywordsdc.subjectIschemia-Reperfusion injury
Keywordsdc.subjectNf-Kappa-B
Keywordsdc.subjectSuperoxide radical generation
Keywordsdc.subjectInduced oxidative stress
Keywordsdc.subjectMuscle in-vivo
Keywordsdc.subjectRat-liver
Keywordsdc.subjectHepatocyte proliferation
Keywordsdc.subjectGene-expression
Títulodc.titleThyroid hormone in the frontier of cell protection, survival and functional recoveryen_US
Document typedc.typeArtículo de revista


Files in this item

Icon

This item appears in the following Collection(s)

Show simple item record

Atribución-NoComercial-SinDerivadas 3.0 Chile
Except where otherwise noted, this item's license is described as Atribución-NoComercial-SinDerivadas 3.0 Chile